mRNA m5C Alteration in Azacitidine Demethylation Treatment of Acute Myeloid Leukemia
Molecular Carcinogenesis · 2025-03 · 64 (3) · 502-512
DOI: 10.1002/mc.23864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 17.12.2024. Verfasst von Ziwei Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hosp…. Hauptthemen laut MEDLINE: Azacitidine, Leukemia, Myeloid, Acute, RNA, Messenger, DNA Methylation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by National High Level Hospital Clinical Research Funding (BJ-2023-078), Beijing natural science foundation (No. 7222158), CAMS Innovat….
Abstract (Originalsprache)
The DNA demethylating therapy with azacitidine (AZA) is a promising therapeutic strategy for elderly patients with acute myeloid leukemia (AML). AZA primarily inhibits DNA methylation, promotes cell differentiation and apoptosis in AML. However, as a cytosine nucleoside analog, AZA also has the potential to be incorporated into RNA molecules. To assess the impact of AZA on RNA m5C methylation during demethylating therapy, we conducted Nanopore direct‐RNA sequencing on samples from three AML patients pre and after demethylating therapy, as well as on HL‐60 cells pretreated with AZA. We performed an integrated analysis of the transcriptome and the m5C methylome, contrasting the states of complete remission with those of active disease (AML). Our results revealed an extensive demethylation effect at the RNA level attributable to AZA and found that mRNA m5C modification may play a pivotal role in the progression of AML. Additionally, S100P was identified as a biomarker with significant prognostic implications. We also conducted a conjoint analysis of the transcriptome and the m5C methylome of the full‐length transcripts, uncovering several dysregulated mRNA isoforms. Collectively, our findings indicate that mRNA m5C methylation is implicated during AML progression, and AZA exhibits an overall suppressive effect on this process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Bei…
- Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
- Clinical Biobank, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
- Center of Laboratory Medicine, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases…
- Department of Hematology, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Ziwei Chen, Chang Li
Förderung
- This work was supported by National High Level Hospital Clinical Research Funding (BJ-2023-078), Beijing natural science foundation (No. 7222158), CAMS Innovat…
Zitieren
APA
Chen, Z., Guo, Y., Zhang, Z., Li, C., Zhang, L., Liu, Y., Sun, G., Xiao, F., Feng, R., & Zhang, C. (2025). mRNA m5C Alteration in Azacitidine Demethylation Treatment of Acute Myeloid Leukemia. Molecular Carcinogenesis, 64(3), 502-512. https://doi.org/10.1002/mc.23864
Vancouver
Chen Z, Guo Y, Zhang Z, Li C, Zhang L, Liu Y, et al. mRNA m5C Alteration in Azacitidine Demethylation Treatment of Acute Myeloid Leukemia. Molecular Carcinogenesis. 2025;64(3):502-512. doi:10.1002/mc.23864
BibTeX
@article{Chen2025,
author = {Chen, Ziwei and Guo, Yingyu and Zhang, Zaifeng and Li, Chang and Zhang, Lili and Liu, Ye and Sun, Gaoyuan and Xiao, Fei and Feng, Ru and Zhang, Chunli},
title = {mRNA m5C Alteration in Azacitidine Demethylation Treatment of Acute Myeloid Leukemia},
journal = {Molecular Carcinogenesis},
year = {2025},
volume = {64},
number = {3},
pages = {502--512},
doi = {10.1002/mc.23864}
}
EUVIMED